Accessibility Menu
Apiam Animal Health logo

Apiam Animal Health(ASX) AHX

This security has been delisted. This page is retained for historical reference.

Apiam Animal Health last closing stock price
MetricPriceDate
Last closeAUD 0.782026-02-06
Apiam Animal Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.57%AUD 0.772026-01-30
1 month+0.57%AUD 0.772026-01-07
3 month+2.34%AUD 0.762025-11-07
Year to date+0.57%AUD 0.772025-12-31
1 year+122.12%AUD 0.352025-02-06
3 year+55.88%AUD 0.502023-02-07
5 year+63.35%AUD 0.472021-02-05
Since inception-9.55%AUD 0.862015-12-15

AHX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

AHX Financials

Key Financial Metrics (TTM)

Gross Margin

66.22%

Operating Margin

6.01%

Net Income Margin

0.40%

Return on Equity

0.68%

Return on Capital

5.56%

Return on Assets

0.33%

Earnings Yield

N/A

Dividend Yield

12.57%

Payout Ratio

3.14%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

A$81.86M

Operating Income

A$59.91M

EBITDA

A$45.14M

Operating Cash Flow

A$36.57M

Capital Expenditure

-A$10.76M

Free Cash Flow

A$25.81M

Cash & ST Invst.

A$2.52M

Total Debt

A$102.54M

Apiam Animal Health Performance Analysis

Apiam Animal Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 157,057,000N/A
20232023-06-30AUD 191,757,00022.1%
20242024-06-30AUD 204,656,0006.7%
20252025-06-30AUD 206,924,0001.1%
Apiam Animal Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-12-316.5%
Q42024-06-30-3.9%
Q22024-12-315.9%
Q42025-06-30-5.1%
Apiam Animal Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD 0.03N/A
20232023-06-30AUD 0.01-61.9%
20242024-06-30AUD 0.03111.7%
20252025-06-30AUD 0.00-83.8%
Apiam Animal Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-12-31620.0%
Q42024-06-30-50.5%
Q22024-12-31-193.3%
Q42025-06-30253.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

A$100.76M

+2.8%

Gross Profit

A$16.06M

+31.9%

Gross Margin

15.94%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

950

N/A

Net Income

A$2.36M

+479.2%

EBITDA

A$12.50M

+85.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

A$2.52M

-20.5%

Total Debt

A$102.54M

+4.6%

Accounts Receivable

A$12.91M

-7.5%

Inventory

A$15.42M

-0.3%

Long Term Debt

A$96.54M

+7.1%

Short Term Debt

A$6.00M

-24.3%

Return on Assets

0.33%

N/A

Return on Invested Capital

5.61%

N/A

Free Cash Flow

A$6.44M

+38.4%

Operating Cash Flow

A$9.17M

-8.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VVA.AXViva Leisure Limited
A$1.53-1.29%
SHJ.AXShine Justice Ltd
A$0.59+0.00%
JYC.AXJoyce Corporation Ltd
A$6.40+4.92%
MHJ.AXMichael Hill International Limited
A$0.35+4.48%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.